AllSight
Companies · NTRA · Services-Medical Laboratories

Natera, Inc. (NTRA)

Natera, Inc. (NTRA) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Natera, Inc. (NTRA) stock — financials & valuation

Key numbers for Natera, Inc. (NTRA): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 38/100 — a percentile rank of Natera, Inc.’s fundamentals against Services peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$59.6B
P / S22.0×
EV / EBITDA-259.6×
Gross margin65.2%
Operating margin-10.7%
Net margin-7.1%
Return on equity-10.6%
ROIC-27.2%
Revenue growth37.8%
Debt / equity0.0×
Dividend yield0.0%

Is Natera, Inc. overvalued? P/S looks overvalued vs its 5-year range; P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from Natera, Inc.’s own financial statements and shown as context, never as advice.

Aug 6, 2026
Revenue and EPS beat expectations, but accruals cloud margin quality
Related companies in Services-Medical Laboratories
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact